+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-02-13Number of Pages: 136

Dermatology Diagnostic Devices and Therapeutics Market (Diagnostic Devices - Dermatoscopes (Contact Oil Immersion Dermatoscopes, Cross-polarized Dermatoscopes, and Hybrid Dermatoscopes), Microscopes and Trichoscopes (Multispectral Photoacaustic Microscopy (PAM), Reflectance Confocal Microscopy (RCM), and Raman Spectroscopy), and Imaging Equipment (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, and Optical Coherence Tomography (OCT)); Drug Class - Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants, and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

As the incidence of chronic skin conditions such as psoriasis, acne, rosacea, eczema, cell carcinoma, pruritus, and dermatitis increases globally, in return it will create opportunities for the expansion of the dermatology diagnostic devices and therapeutics market.  Besides, having an adverse impact on the well-being of millions, these diseases also put burden on an economy’s healthcare finances. As per Transparency Market Research (TMR), skin conditions such as these permeate all cultures, they can occur at any age, and affects 30% to 70% individuals globally. The situation necessitates the efficient research and development on novel dermatology therapeutics.

The global dermatology diagnostic devices and therapeutics market will therefore gain from the rising prevalence of such chronic ailments, increasing geriatric population, and the changing pool of patients. However, with the implementation of the Affordable Care Act and the looming patent expirations, the growth trajectory of the market is likely to be hindered to an extent. Nevertheless, TMR projects positive growth for the market between 2015 and 2023.

Rising at a CAGR of 6.9% between 2015 and 2023, the global market for dermatology diagnostic devices is poised to reach US$1 bn 2023, from a valuation of US$0.6 bn in 2014. Conversely, the global dermatology therapeutics market is projected to expand at a CAGR of 1.9% during the forecast period, rising from a valuation of US$17.5 bn in 2014 to US$20.1 bn in 2023.

North America Emerges at Fore of Global Dermatology Diagnostic Devices and Therapeutics Market

Regionally, North America has emerged at the fore of the dermatology diagnostic devices and therapeutics market. The region constituted a share of 43.8% in 2014, thus sealing its dominance in the global market. Besides witnessing a growing prevalence of skin disorders, North America also boasts easy access to best-in-class healthcare facilities. This makes the region very lucrative for most companies operating in the market. Growth witnessed by the dermatology diagnostic devices and therapeutics market in the region has been a result of the presence of a highly structured healthcare industry and access to well-designed reimbursement policies.

The dermatology diagnostic devices market stood at US$245.1 mn in North America and is projected to reach US$470.4 mn by the end of 2023, thus exhibiting a CAGR of 7.6% during the period. The dermatology therapeutics market in the region however is expected to report moderate growth in the forecast period. It is poised to surge at 2.1% CAGR between 2015 and 2023.

While Europe is expected to emerge as the second-largest market for dermatology diagnostic devices and therapeutics, the distinction of the fastest growing market will remain with Asia Pacific. The latter is expected to demonstrate the fastest CAGR of 2.4% during the forecast period. The presence of large pool of geriatric population in Asia Pacific, apart from increasing healthcare spending in the emerging economies is boosting prospects for the market in the region. The increasing government support will also prove lucrative for the enterprises operating in Asia Pacific.

Demand for Antibacterial Drugs to Surge in Response to Increasing Incidence of Chronic Skin Conditions

In the dermatology diagnostics market, the demand for imaging equipment is rising at a high pace. The segment also accounted for the dominant share of in the market in 2014 based on revenue. The lead of this product segment is largely attributed by the high price of imaging equipment. However, TMR projects the demand for high sensitivity imaging equipment to rise at a faster pace in the near future due to their proven result in diagnosis of chronic skin diseases.

By drug class, antibacterial drugs accounted for the largest share in the global dermatology therapeutics market. This segment is projected to report a CAGR of 3.3% during the forecast period. The demand for these drugs are expected to increasing in the forthcoming years because they have proven efficient treating and preventing infections. Furthermore, the demand for topical antibacterial drugs and oral antibiotics is also expected to rise in the future due to their use in the treatment of various skin conditions.

Some of the leading companies operating in the global dermatology diagnostic devices and therapeutics market include  Astellas Pharma, Inc., Agfa-Gevaert N.V., Novartis International AG, Cutera, Inc., Galderma S.A., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson Diagnostics Ltd., Valeant Pharmaceuticals International, Inc., and others. 

Section - 1 Preface 
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. Research Methodology : Assumptions

Section - 2 Executive Summary: Global Dermatology Diagnostic Devices and Therapeutics Market 
2.1. Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, By Revenue, 2014–2024 (US$ Mn)
2.2. Global Dermatology Diagnostic Devices Market, by Product, 2015 (US$ Mn)
2.3. Global Dermatology Therapeutics Market, by Drug Class, 2015 (US$ Mn)
2.4. Global Market Share by Geography (Diagnostic Devices), 2015 and 2024 (Value %)
2.5. Global Market Share by Geography (Therapeutics), 2015 and 2024 (Value %)
2.6. Dermatology Diagnostic Devices Market Snapshot
2.7. Dermatology Therapeutics Market Snapshot 

Section-3 Market Overview: Global Dermatology Diagnostic Devices and Therapeutics Market
3.1. Introduction and Market Definition
3.2. Market Dynamics
       3.2.1. Drivers
       3.2.2. Restraints
       3.2.3. Opportunities
3.3. Porter’s five forces analysis
3.4. Company Market Share
       3.4.1. Company Market Share : Dermatology Diagnostic Devices Market (2015)
       3.4.2. Company Market Share : Dermatology Therapeutics Market (2015)
3.5. Market Attractiveness Analysis
       3.5.1. Market Attractiveness Analysis : Dermatology Diagnostic Devices Market
       3.5.2. Market Attractiveness Analysis : Dermatology Therapeutics Market
       3.5.3. Market Attractiveness Analysis : By Geography
3.6. Overview of Skin Diseases

Section-4 Global Dermatology Diagnostic Devices Market Segmentation, By Product
4.1. Introduction 
4.2. Global Dermatology Diagnostic Devices Market, by Product, 2014–2024 (US$ Mn)
4.3. Global Dermatoscope Market Revenue 2014–2024 (US$ Mn)
       4.3.1. Global Dermatoscope Market Revenue, By Product 2014–2024 (US$ Mn)
4.4. Global Dermatology Microscopes and Trichoscopes Market Revenue 2014–2024 (US$ Mn)
       4.4.1. Global Dermatology Microscopes and Trichoscopes Market Revenue, By Product 2014–2024 (US$ Mn)
4.5. Global Dermatology Imaging Equipment Market Revenue 2014–2024 (US$ Mn)
       4.5.1. Global Dermatology Imaging Equipment Market Revenue, By Product 2014–2024 (US$ Mn)

Section-5 Global Dermatology Therapeutics Market Segmentation, By Drug Class
5.1. Introduction
5.2. Global Dermatology Therapeutics Market, by Drug Class, 2014–2024 (US$ Mn)
       5.2.1. Global Antibacterials for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.2. Global Antifungal Agents for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.3. Global Antiviral Agents for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.4. Global Corticosteroids for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.5. Global Retinoids for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.6. Global Immunosuppresants for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.7. Global Biologics for Dermatology Market Revenue, 2014–2024 (US$ Mn)

Section-6 Market Segmentation – By Pipeline Assessment
6.1. Global Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3
6.2. Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn)

Section-7 Global Dermatology Diagnostic Devices and Therapeutics Market Segmentation, By Region
7.1. Overview
       7.1.1. Global Dermatology Diagnostic Devices Market Revenue, by Geography, 2014–2024 (US$ Mn)
       7.1.2. Global Dermatology Therapeutics Market Revenue, by Geography, 2014–2024 (US$ Mn)
7.2. North America Dermatology Diagnostic Devices and Therapeutics Market
       7.2.1. North America Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.2.2. North America Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.2.2.1. North America Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.2.2.2. North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.2.2.3. North America Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.2.3. North America Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.2.4. North America Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.3. Europe Dermatology Diagnostic Devices and Therapeutics Market
       7.3.1. Europe Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.3.2. Europe Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.3.2.1. Europe Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.3.2.2. Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.3.2.3. Europe Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.3.3. Europe Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.3.4. Europe Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.4. Asia Pacific Dermatology Diagnostic Devices and Therapeutics Market
       7.4.1. Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.4.2. Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.4.2.1. Asia Pacific Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.4.2.2. Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.4.2.3. Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.4.3. Asia Pacific Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.4.4. Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.5. Latin America Dermatology Diagnostic Devices and Therapeutics Market
       7.5.1. Latin America Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.5.2. Latin America Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.5.2.1. Latin America Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.5.2.2. Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.5.2.3. Latin America Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.5.3. Latin America Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.5.4. Latin America Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.6. Middle East and North Africa (MENA) Dermatology Diagnostic Devices and Therapeutics Market
       7.6.1. MENA Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.6.2. MENA Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.6.2.1. MENA Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.6.2.2. MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.6.2.3. MENA Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.6.3. MENA Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.6.4. MENA Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.7. Rest of the World (ROW) Dermatology Diagnostic Devices and Therapeutics Market
       7.7.1. ROW Dermatology Diagnostic Devices Market Revenue, 2014–2024 (US$ Mn)
       7.7.2. ROW Dermatology Therapeutics Market Revenue, 2014–2024 (US$ Mn)

Section-8 Historical Snapshot and Current Trends

Section-9 Company Profiles
9.1 Agfa-Gevaert N.V.
       9.1.1 Company Overview (HQ, Business Segments, Employee Strength)
       9.1.2 Financial Overview
       9.1.3 Product Portfolio
       9.1.4 Strategic Overview
9.2 Astellas Pharma, Inc. 
       9.2.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.2.2. Financial Overview
       9.2.3. Product Portfolio
       9.2.4. Strategic Overview
9.3 Cutera, Inc. 
       9.3.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.3.2. Financial Overview
       9.3.3. Product Portfolio
       9.3.4. Strategic Overview
9.4 Dino-Lite Europe/IDCP BV. 
       9.4.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.4.2. Product Portfolio
       9.4.3. Strategic Overview
9.5 Galderma S.A. 
       9.5.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.5.2. Financial Overview
       9.5.3. Product Portfolio
       9.5.5. Strategic Overview
9.6 Genentech, a Roche Company 
       9.6.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.6.2. Product Portfolio
       9.6.3. Strategic Overview
9.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.) 
       9.7.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.7.2. Financial Overview
       9.7.3. Product Portfolio
       9.7.4. Strategic Overview
9.8 LEO Pharma A/S
       9.8.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.8.2. Financial Overview
       9.8.3. Product Portfolio
       9.8.4. Strategic Overview
9.9 Michelson Diagnostics Ltd.
       9.9.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.9.2. Product Portfolio
       9.9.3. Strategic Overview
9.10 Novartis International AG 
       9.10.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.10.2. Financial Overview
       9.10.3. Product Portfolio
       9.10.4. Strategic Overview
9.11 Valeant Pharmaceuticals International, Inc.
       9.11.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.11.2. Financial Overview
       9.11.3. Product Portfolio
       9.11.4. Strategic Overview
9.12 Canfield Scientific, Inc.
       9.12.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.12.2. Product Portfolio
       9.12.3. Strategic Overview

List of Figures

Figure 01 : Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, by Revenue (US$ Mn), 2014–2024
Figure 02 : Global Dermatology Diagnostic Devices Market, by Product (US$ Mn), 2015
Figure 03 : Global Dermatology Therapeutics Market, by Drug Class (US$ Mn), 2015
Figure 04 : Global Market Share, by Region (Diagnostic Devices) (Value %), 2015 and 2024
Figure 05 : Global Market Share, by Region (Therapeutics), (Value %), 2015 and 2024
Figure 06 : Percentage of Population (U.S., China, Japan, and India) over the age of 65: 1980–2050
Figure 07 : Global Percentage Change in the World’s Population, by Age: 2010–2050
Figure 08 : Market Share Analysis of Key Players, Dermatology Diagnostic Devices Market (%), 2015
Figure 09 : Market Share Analysis of Key Players, Dermatology Therapeutics Market (%), 2015
Figure 10 : Market Attractiveness Analysis, by Device, 2015
Figure 11 : Market Attractiveness Analysis, by Drug Class, 2015
Figure 12 : Market Attractiveness Analysis, by Geography, 2015
Figure 13 : Global Dermatoscopes Market Revenue (US$ Mn), 2014–2024
Figure 14 : Global Microscopes and Trichoscopes Market Revenue (US$ Mn), 2014–2024
Figure 15 : Global Imaging Equipment Market Revenue (US$ Mn), 2014–2024
Figure 16 : Global Antibacterials Market Revenue (US$ Mn), 2014–2024
Figure 17 : Global Antifungal Agents Market Revenue (US$ Mn), 2014–2024
Figure 18 : Global Antiviral Agents Market Revenue (US$ Mn), 2014–2024
Figure 19 : Global Corticosteroids Market Revenue (US$ Mn), 2014–2024
Figure 20 : Global Retinoids Market Revenue (US$ Mn), 2014–2024
Figure 21 : Global Immunosuppressants Market Revenue (US$ Mn), 2014–2024
Figure 22 : Global Biologics Market Revenue (US$ Mn), 2014–2024
Figure 23 : RoW Dermatology Diagnostic Devices Market Revenue, (US$ Mn), 2014–2024
Figure 24 : RoW Dermatology Therapeutics Market Revenue, (US$ Mn), 2014–2024

List of Tables

Table 01 : Global Dermatology Diagnostic Devices Market, by Product, (US$ Mn), 2014–2024
Table 02 : Global Dermatoscopes Market Revenue, by Product, (US$ Mn), 2014–2024
Table 03 : Global Microscopes and Trichoscopes Market Revenue, by Product, (US$ Mn), 2014–2024
Table 04 : Global Imaging Equipment Market Revenue, by Product, (US$ Mn) , 2014–2024
Table 05 : Global Dermatology Therapeutics Market, by Drug Class, (US$ Mn), 2014–2024
Table 06 : Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn) 
Table 07 : Global Dermatology Diagnostic Devices Market Revenue, by Region, (US$ Mn), 2014–2024
Table 08 : Global Dermatology Therapeutics Market Revenue, by Region, (US$ Mn), 2014–2024
Table 09 : North America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 10 : North America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 11 : North America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 12 : North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 13 : North America Dermatology Imaging Equipment Market Revenue, by Product Type, 2014–2024 (US$ Mn)
Table 14 : North America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024 
Table 15 : North America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 16 : Europe Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 17 : Europe Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 18 : Europe Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 19 : Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 20 : Europe Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 21 : Europe Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 22 : Europe Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 23 : APAC Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 24 : Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 25 : Asia Pacific Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 26 : Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 27 : Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 28 : Asia Pacific Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 29 : Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 30 : Latin America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 31 : Latin America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 32 : Latin America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 33 : Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 34 : Latin America Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 35 : Latin America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 36 : Latin America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 37 : MENA Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 38 : MENA Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 39 : MENA Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 40 : MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 41 : MENA Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 42 : MENA Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 43 : MENA Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024

Dermatology Diagnostic Devices and Therapeutics Market: Scope and Methodology

This report on the global dermatology diagnostic devices and therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global dermatology diagnostic devices and therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global dermatology diagnostic devices and therapeutics market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of product features of different types of diagnostic devices and therapeutics. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of acute skin conditions, chronic skin conditions, skin infections and other dermatology diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Dermatology Diagnostic Devices and Therapeutics Market: Segmentation

Based on product type, the global dermatology diagnostic devices market has been segmented dermatoscopes, microscopes & trichoscopes, and imaging equipment. These segments are further categorized into sub-segments such as contact oil immersion devices, cross-polarized devices and hybrid devices in dermatoscope segment; multispectral confocal microscope, reflectance confocal microscope, Raman spectroscope, and others in dermatology microscopes and trichoscopes segment; and imaging equipment are sub-segmented into x-ray, magnetic resonance imaging, ultrasound, optical coherence tomography, and others.

Based on the drug class, global dermatology therapeutics market is sub-segmented into antibacterial agents, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppressant, and biologics.

Geographically, the global dermatology diagnostic devices and therapeutics market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, China, Japan, India, Australia, Brazil, Egypt, Kuwait, Saudi Arabia, and UAE.

Dermatology Diagnostic Devices and Therapeutics Market: Geographical and Competitive Dynamics

The report also profiles major players in the dermatology diagnostic devices and therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc., LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, Valeant Pharmaceuticals International, Inc., Canfield Scientific, Inc.

Global dermatology diagnostic devices and therapeutics market has been segmented as follows:

Global Dermatology Diagnostic Devices Market, by Product Type

  • Dermatoscopes
    • Contact Oil Immersion Dermatoscope
    • Cross-Polarized Dermatoscopes
    • Hybrid Dermatoscope
  • Microscopes and Trichoscopes
    • Multispectral Photoacaustic Microscopy (PAM)
    • Reflectance Confocal Microscopy (RCM)
    • Raman Spectroscopy
    • Others
  • Imaging Equipment
    • X-ray
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound
    • Optical Coherence Tomography (OCT)
    • Others

Global Dermatology Therapeutics Market, by Drug Class

  • Antibacterial Agents
  • Antifungal Agents
  • Antiviral Agents
  • Corticosteroids
  • Retinoids
  • Immunosuppressants
  • Biologics

Global Dermatology Diagnostic Devices and Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & North Africa
    • Egypt
    • Kuwait
    • Saudi Arabia
    • UAE
    • Rest of Middle East & North Africa
  • Rest of the World (RoW)


 
 
Back To Top